Clinical Trial Update: Donepezil and Memantine in Moderate to Severe Alzheimer's Disease [Phase 4]

View source ↗

Summary

This is an update on a Phase 4 clinical trial assessing the combination of donepezil and memantine in moderate to severe Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Aricept (Donepezil)
• Namenda (memantine)

Snippet

Sponsor: King's College London | Conditions: Moderate to Severe Alzheimer's Disease | Phase 4 | Status: UNKNOWN